Skip to main content
Kashyap Patel, MD, Oncology, Rock Hill, SC

KashyapBPatelMD

Oncology Rock Hill, SC

CEO;Carolina Blood and Cancer Care; Immediate Past President, Community Oncology Alliance

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Patel's full profile

Already have an account?

  • Office

    1583 Health Care Dr
    Rock Hill, SC 29732
    Phone+1 803-329-7772
    Fax+1 803-329-9821

Summary

  • Kashyap Patel is the CEO of Carolina Blood and Cancer Care Associates. Dr. Patel is a practicing medical oncologist, board certified in Hematology, Oncology, and Internal Medicine. He is immediate past president for the Community Oncology Alliance (COA), He is past for the clinical affairs and trustee for the Association of Community Cancer Centers (ACCC). He has published/presented over 130 papers. He is frequently interviewed and cited in mainstream newspapers including NY times, Washington Post, NPR just to name a few including on key issues like Covid 19, Healthcare disparities, value-based care. He is also frequenly invited by WH team to opine of Cancer Moonshot program
    He has been an advisor for the large payers including DHHS (SC), Palmetto GBA, and serves on an advisory board for Medicaid HMOs. He has a special interest in health care policy and economics, and he has expertise in Value Based Care and has successfully led Oncology Care Model pilots with two payers including with CMMI
    Additionally, Dr Patel has been working directly with cancer patients for the last twenty years. He has served as chairman of several committees in numerous South Carolina hospitals. Moreover, he has extensive research experience in oncology. Dr. Patel has extensive legislative experience both at the local and national level. He has testified in state senate as well as has carried out capitol hill briefing on precision medicine.
    He has been honored by the US Congress for his exceptional contribution to the healthcare. Multiple journals have written about his life. He is now working with multiple national entities on cancer health disparities

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Jamaica Hospital Medical Center
    Jamaica Hospital Medical CenterResidency, Internal Medicine, 1996 - 1999
  • N.H.L Municipal Medical College
    N.H.L Municipal Medical CollegeClass of 1984

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2003 - 2025
  • SC State Medical License
    SC State Medical License 2002 - 2025
  • NY State Medical License
    NY State Medical License 1999 - 2018
  • FL State Medical License
    FL State Medical License 2002 - 2006
  • PA State Medical License
    PA State Medical License 1999 - 2006
  • NJ State Medical License
    NJ State Medical License 2000 - 2005
  • MI State Medical License
    MI State Medical License 1999 - 2000
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

Press Mentions

  • Oxford Biodynamics to Present on Its Line of EpiSwitch® Products for Companion Diagnostics in Cancer Immunotherapy at the 14th World Summit for Clinical Biomarkers and Companion Diagnostics in Boston, MA
    Oxford Biodynamics to Present on Its Line of EpiSwitch® Products for Companion Diagnostics in Cancer Immunotherapy at the 14th World Summit for Clinical Biomarkers and Companion Diagnostics in Boston, MAJuly 25th, 2024
  • Covid Might Be to Blame for an Uptick in Rare Cancers
    Covid Might Be to Blame for an Uptick in Rare CancersJune 20th, 2024
  • Rare and ‘Unusual’ Cancers Are Emerging After the Covid Pandemic – and Doctors Fear an Unlikely Culprit Is to Blame
    Rare and ‘Unusual’ Cancers Are Emerging After the Covid Pandemic – and Doctors Fear an Unlikely Culprit Is to BlameJune 7th, 2024
  • Join now to see all